EDWARD TROY SCHUMANN
- Type
- Physician · Allopathic & Osteopathic Physicians / Family Medicine
- Where
- FLORENCE, KY
- NPI
- 1194786061
- Received
- $79,489 in 223 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 123 | $64,882 |
| 2024 | General payment | 49 | $13,707 |
| 2023 | General payment | 11 | $320 |
| 2022 | General payment | 10 | $157 |
| 2021 | General payment | 8 | $128 |
| 2020 | General payment | 8 | $109 |
| 2019 | General payment | 14 | $183 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Lilly USA, LLC | 143 | $74,678 | 2024–2025 |
| Novo Nordisk Inc | 54 | $4,183 | 2019–2025 |
| Rhythm Pharmaceuticals, Inc. | 8 | $226 | 2022–2024 |
| Corcept Therapeutics | 4 | $104 | 2023–2024 |
| Novartis Pharmaceuticals Corporation | 1 | $80 | 2024 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $77 | 2022–2024 |
| Currax Pharmaceuticals LLC | 4 | $51 | 2019–2021 |
| Teleflex LLC | 1 | $20 | 2025 |
| Endo Pharmaceuticals Inc. | 1 | $19 | 2019 |
| Solventum Corporation | 1 | $16 | 2024 |
| Innocoll Pharmaceuticals Limited | 1 | $15 | 2021 |
| Allergan, Inc. | 1 | $15 | 2019 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 83 | $66,500 |
| Travel and Lodging | 18 | $5,446 |
| Food and Beverage | 119 | $4,683 |
| Consulting Fee | 1 | $2,795 |
| Education | 2 | $64 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-03 | Novo Nordisk Inc | $15 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-11-24 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-11-20 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-11-18 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-11-14 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-11-10 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-11-09 | Novo Nordisk Inc | $18 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-11-07 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-11-05 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-10-29 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-10-27 | Lilly USA, LLC | $1,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-10-27 | Lilly USA, LLC | $525 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-10-23 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-10-22 | Lilly USA, LLC | $120 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-10-22 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-10-21 | Novo Nordisk Inc | $97 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-10-16 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-10-16 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-10-15 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-10-09 | Lilly USA, LLC | $1,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-10-09 | Lilly USA, LLC | $875 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-10-06 | Novo Nordisk Inc | $32 | Education | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-10-06 | Lilly USA, LLC | $9 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-09-29 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-09-16 | Lilly USA, LLC | $11 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-09-08 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-09-05 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-08-29 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-08-26 | Novo Nordisk Inc | $15 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-08-25 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-08-20 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-08-19 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-08-15 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-08-15 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-08-12 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-08-11 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-08-01 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-28 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-23 | Novo Nordisk Inc | $20 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-07-15 | Lilly USA, LLC | $14 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-07-15 | Lilly USA, LLC | $1 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-07-14 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-10 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-27 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-25 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-17 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-12 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-11 | Teleflex LLC | $20 | Food and Beverage | In-kind items and services | TITAN SGS BAILOUT CHUCK Device, SURGICAL | 2025 | |
| 2025-06-09 | Novo Nordisk Inc | $2,795 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-06-09 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-09 | Lilly USA, LLC | $350 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-03 | Lilly USA, LLC | $16 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-02 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-02 | Novo Nordisk Inc | $17 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-05-28 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-23 | Lilly USA, LLC | $1,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-23 | Lilly USA, LLC | $525 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-21 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-21 | Lilly USA, LLC | $116 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-20 | Lilly USA, LLC | $1,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-20 | Lilly USA, LLC | $525 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-19 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-16 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-16 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-16 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-15 | Novo Nordisk Inc | $110 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-05-09 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-08 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-05 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-28 | Novo Nordisk Inc | $19 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-04-27 | Novo Nordisk Inc | $61 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-04-24 | Novo Nordisk Inc | $41 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-04-23 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-18 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-16 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-14 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-14 | Lilly USA, LLC | $14 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-04-09 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-08 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-07 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-07 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-04 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-01 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-31 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-28 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-27 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-26 | Novo Nordisk Inc | $97 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-03-18 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-12 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-11 | Lilly USA, LLC | $350 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-10 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-06 | Novo Nordisk Inc | $28 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-02-21 | Lilly USA, LLC | $1,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-02-21 | Lilly USA, LLC | $525 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-02-20 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-02-19 | Lilly USA, LLC | $98 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-02-03 | Novo Nordisk Inc | $19 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-01-30 | Lilly USA, LLC | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-30 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-23 | Lilly USA, LLC | $2,031 | Travel and Lodging | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-23 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-23 | Lilly USA, LLC | $545 | Travel and Lodging | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-23 | Lilly USA, LLC | $419 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-01-23 | Lilly USA, LLC | $253 | Travel and Lodging | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-23 | Lilly USA, LLC | $253 | Travel and Lodging | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-23 | Lilly USA, LLC | $253 | Travel and Lodging | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-23 | Lilly USA, LLC | $253 | Travel and Lodging | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-23 | Lilly USA, LLC | $253 | Travel and Lodging | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-23 | Lilly USA, LLC | $115 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-23 | Lilly USA, LLC | $60 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-23 | Lilly USA, LLC | $55 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-23 | Lilly USA, LLC | $39 | Travel and Lodging | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-23 | Lilly USA, LLC | $39 | Travel and Lodging | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-23 | Lilly USA, LLC | $39 | Travel and Lodging | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-23 | Lilly USA, LLC | $39 | Travel and Lodging | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-23 | Lilly USA, LLC | $39 | Travel and Lodging | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-23 | Lilly USA, LLC | $35 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-23 | Lilly USA, LLC | $35 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-23 | Lilly USA, LLC | $25 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-23 | Lilly USA, LLC | $25 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-23 | Lilly USA, LLC | $25 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-23 | Lilly USA, LLC | $10 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-09 | Lilly USA, LLC | $13 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2024-12-17 | Novo Nordisk Inc | $19 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-11-12 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-11-07 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-11-04 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-10-16 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-10-15 | Novo Nordisk Inc | $124 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-10-14 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-10-08 | Novo Nordisk Inc | $19 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-09-26 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-09-17 | Lilly USA, LLC | $700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-09-09 | Lilly USA, LLC | $1,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-09-09 | Lilly USA, LLC | $525 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-09-05 | Lilly USA, LLC | $19 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-09-05 | Lilly USA, LLC | $3 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-09-05 | Lilly USA, LLC | $1 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-08-13 | Lilly USA, LLC | $13 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-08-02 | Novo Nordisk Inc | $18 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-08-01 | Novo Nordisk Inc | $32 | Education | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-07-17 | Solventum Corporation | $16 | Food and Beverage | Cash or cash equivalent | PREVENA Device, Negative Pressure Systems & Dressings | 2024 | |
| 2024-07-01 | Lilly USA, LLC | $22 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-07-01 | Lilly USA, LLC | $22 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-07-01 | Lilly USA, LLC | $7 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-06-20 | Lilly USA, LLC | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-06-13 | Lilly USA, LLC | $1,317 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-06-13 | Lilly USA, LLC | $541 | Travel and Lodging | In-kind items and services | 2024 | ||
| 2024-06-13 | Lilly USA, LLC | $208 | Travel and Lodging | In-kind items and services | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-06-13 | Lilly USA, LLC | $189 | Travel and Lodging | In-kind items and services | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-06-13 | Lilly USA, LLC | $120 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-06-13 | Lilly USA, LLC | $70 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-06-13 | Lilly USA, LLC | $70 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-06-13 | Lilly USA, LLC | $55 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-06-13 | Lilly USA, LLC | $35 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-06-13 | Lilly USA, LLC | $25 | Travel and Lodging | In-kind items and services | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-06-13 | Lilly USA, LLC | $25 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-06-13 | Lilly USA, LLC | $25 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-06-13 | Lilly USA, LLC | $20 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-06-13 | Lilly USA, LLC | $11 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-05-22 | Lilly USA, LLC | $13 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-05-14 | Rhythm Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | IMCIVREE Drug, Genetic Disease | 2024 | |
| 2024-04-30 | Takeda Pharmaceuticals U.S.A., Inc. | $20 | Food and Beverage | In-kind items and services | EOHILIA Drug, INTERNAL MEDICINE | 2024 | |
| 2024-04-26 | Novo Nordisk Inc | $99 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-04-15 | Novo Nordisk Inc | $10 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-04-04 | Lilly USA, LLC | $12 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-03-06 | Lilly USA, LLC | $16 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-03-01 | Novartis Pharmaceuticals Corporation | $80 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2024 | |
| 2024-02-07 | Lilly USA, LLC | $15 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-02-06 | Corcept Therapeutics | $23 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2024 | |
| 2024-01-19 | Novo Nordisk Inc | $15 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-01-04 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2024 | |
| 2023-12-14 | Corcept Therapeutics | $28 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2023 | |
| 2023-11-02 | Corcept Therapeutics | $24 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2023 | |
| 2023-10-24 | Takeda Pharmaceuticals U.S.A., Inc. | $21 | Food and Beverage | In-kind items and services | GATTEX Drug, INTERNAL MEDICINE | 2023 | |
| 2023-10-19 | Novo Nordisk Inc | $17 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2023-09-26 | Corcept Therapeutics | $27 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2023 | |
| 2023-09-14 | Rhythm Pharmaceuticals, Inc. | $119 | Food and Beverage | In-kind items and services | Imcivree Drug, Genetic Disease | 2023 | |
| 2023-09-08 | Rhythm Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | Imcivree Drug, Genetic Disease | 2023 | |
| 2023-05-26 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2023-02-27 | Rhythm Pharmaceuticals, Inc. | $10 | Food and Beverage | In-kind items and services | Imcivree Drug, Genetic Disease | 2023 | |
| 2023-02-09 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2023-01-23 | Novo Nordisk Inc | $22 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2022-08-31 | Takeda Pharmaceuticals U.S.A., Inc. | $17 | Food and Beverage | In-kind items and services | GATTEX Drug, INTERNAL MEDICINE | 2022 | |
| 2022-08-29 | Novo Nordisk Inc | $12 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2022 | |
| 2022-08-25 | Rhythm Pharmaceuticals, Inc. | $14 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-07-18 | Rhythm Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-07-12 | Novo Nordisk Inc | $19 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2022 | |
| 2022-05-25 | Rhythm Pharmaceuticals, Inc. | $13 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-05-03 | Novo Nordisk Inc | $17 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2022 | |
| 2022-04-04 | Takeda Pharmaceuticals U.S.A., Inc. | $18 | Food and Beverage | In-kind items and services | GATTEX Drug, INTERNAL MEDICINE | 2022 | |
| 2022-03-08 | Novo Nordisk Inc | $11 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2022 | |
| 2022-03-03 | Rhythm Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | 2022 | ||
| 2021-12-17 | Innocoll Pharmaceuticals Limited | $15 | Food and Beverage | In-kind items and services | XARACOLL Drug, PAIN | 2021 | |
| 2021-11-08 | Novo Nordisk Inc | $18 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2021 | |
| 2021-10-18 | Novo Nordisk Inc | $13 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2021 | |
| 2021-08-09 | Novo Nordisk Inc | $17 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2021 | |
| 2021-06-28 | Novo Nordisk Inc | $20 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2021 | |
| 2021-03-15 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2021 | |
| 2021-01-25 | Currax Pharmaceuticals LLC | $14 | Food and Beverage | In-kind items and services | CONTRAVE Drug, OBESITY | 2021 |
The latest 200 records of 223.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Florence, KY, county Boone County, KY, state Kentucky; placed by its city name.
| Measure | Place (city or town) Florence, KY | County Boone County, KY | State Kentucky |
|---|---|---|---|
| Population B01003 | 32,803 | 139,841 | 4,534,824 |
| Population, 2020 census P1 | 31,946 | 135,968 | 4,505,836 |
| Median age B01002 | 38.9 | 37.7 | 39.1 |
| Under 18 B01001 | 20.7% | 25.6% | 22.6% |
| 65 and over B01001 | 19.6% | 14.9% | 17.3% |
| Households B11001 | 13,926 | 50,963 | 1,814,469 |
| Foreign born B05002 | 9.4% | 6.3% | 4.7% |
| Median household income B19013 | $71,003 | $99,414 | $63,726 |
| Median family income B19113 | $82,476 | $116,259 | $81,505 |
| Per capita income B19301 | $40,622 | $46,264 | $35,821 |
| Poverty rate B17001 | 9.5% | 6.3% | 16.1% |
| Unemployment rate B23025 | 3.1% | 3.1% | 4.9% |
| Civilian labor force B23025 | 17,010 | 73,032 | 2,152,038 |
| Mean commute (minutes) B08013 | 23.3 | 25.0 | 24.0 |
| Bachelor's degree or higher B15003 | 26.4% | 35.7% | 27.6% |
| Housing units B25001 | 14,499 | 53,195 | 2,023,116 |
| Owner-occupied B25003 | 57.5% | 76.3% | 68.3% |
| Renters B25003 | 42.5% | 23.7% | 31.7% |
| Median home value B25077 | $210,700 | $277,300 | $205,600 |
| Median gross rent B25064 | $1,329 | $1,373 | $967 |
| White, not Hispanic B03002 | 77.0% | 82.3% | 81.5% |
| Black B03002 | 6.7% | 4.4% | 7.6% |
| Hispanic or Latino B03002 | 9.2% | 5.9% | 5.0% |
| Asian B03002 | 3.4% | 2.4% | 1.6% |
| American Indian and Alaska Native B03002 | 0.0% | 0.0% | 0.1% |
Economy now FRED unemployment 4.7% in Sep 2026 (4.5% a year earlier); per capita personal income $60,835 in 2025, up 29% in five years (+3.9% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Florence, KY.
Comments